| |
| |
|
| Insider
Information: |
Patton John Stuart |
| Relationship: |
Chief Scientific Offic... |
| City: |
San Diego, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
493,756 |
|
|
Indirect Shares
|
233,444 |
|
|
| Direct
Value |
$8,730,050 |
|
|
|
Indirect Value
|
$10,590,183 |
|
|
| Total
Shares |
727,200 |
|
|
| Total
Value |
$19,320,233 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
Director |
2014-08-19 |
179,876 |
2005-01-18 |
232,830 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Chief Scientific Offic... |
2008-11-14 |
313,880 |
2006-05-15 |
614 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-10-02 |
4 |
AS |
$8.79 |
$133,471 |
D/D |
(15,000) |
45,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-10-09 |
4 |
AS |
$8.62 |
$130,306 |
D/D |
(15,000) |
30,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-10-16 |
4 |
AS |
$8.92 |
$135,628 |
D/D |
(15,000) |
15,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2008-05-08 |
4 |
A |
$4.94 |
$74,100 |
D/D |
15,000 |
30,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2009-05-07 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
50,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2010-05-06 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
70,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2011-05-05 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
90,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2012-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
110,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2013-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
130,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2013-09-13 |
4 |
OE |
$0.39 |
$39,000 |
D/D |
100,000 |
230,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2013-09-13 |
4 |
S |
$9.10 |
$341,359 |
D/D |
(37,500) |
192,500 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2013-09-16 |
4 |
S |
$9.16 |
$343,680 |
D/D |
(37,500) |
155,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2014-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
24,876 |
179,876 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2014-08-19 |
4 |
S |
$9.96 |
$746,985 |
D/D |
(75,000) |
179,876 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2014-08-19 |
4 |
OE |
$2.05 |
$153,750 |
D/D |
75,000 |
254,876 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2004-01-13 |
4 |
AS |
$18.18 |
$363,733 |
I/I |
(20,000) |
547,308 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2004-02-10 |
4 |
AS |
$20.00 |
$400,000 |
I/I |
(20,000) |
527,308 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2004-03-01 |
4 |
A |
$0.01 |
$250 |
D/D |
25,000 |
25,000 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2004-03-04 |
4 |
AS |
$22.00 |
$443,522 |
I/I |
(20,000) |
507,308 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2004-12-15 |
4 |
S |
$19.42 |
$66,033 |
I/I |
(3,400) |
2,211 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2004-12-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,030 |
503,278 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2005-01-14 |
4 |
OE |
$18.61 |
$588,076 |
I/I |
31,600 |
534,878 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2005-03-14 |
4 |
A |
$0.00 |
$0 |
I/I |
4,166 |
539,044 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2005-03-14 |
4 |
S |
$14.37 |
$21,368 |
I/I |
(1,487) |
534,878 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2005-05-10 |
4 |
S |
$14.47 |
$25,323 |
I/I |
(1,750) |
1,621 |
|
- |
|
63 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
